9 Meters Biopharma (NMTR) Announces Proposed Public Offering of Common Stock

9 Meters Biopharma, Inc. (NASDAQ: NMTR), a clinical-stage company focused on rare and unmet needs in gastroenterology, announced today that it has commenced a proposed underwritten public offering of shares of its common stock. In connection with this offering, 9 Meters Biopharma expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock to be sold in the offering. All of the shares in the proposed offering are to be sold by 9 Meters Biopharma. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

Citigroup and William Blair & Company, L.L.C. are acting as joint book-running managers for the offering. Truist Securities, Inc. is also acting as a joint book-running manager for the offering. BMO Capital Markets is serving as financial advisor to the Company.

You May Also Be Interested In

• Manulife prices $750M subordinated notes offering at 6.146%
• Sparton, Glen Eagle ink joint venture deal for Ontario silver mine
• Vishay launches two common mode chokes for automotive and industrial use